FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2151493707> ?p ?o ?g. }

• W2151493707 endingPage "394" @default.
• W2151493707 startingPage "386" @default.
• W2151493707 abstract "Several immortalized and malignant adult human prostatic epithelial cell lines have recently been developed. The three most widely used carcinoma cell lines, DU-145, PC-3, and LNCaP, developed between 1977 and 1980, have greatly contributed to our present understanding of prostate cancer. Before a cell line can be accepted as having prostatic epithelial origin, some basic characteristics must be established. Expression of specific cytokeratins, but absence of desmin and factor VIII, should be first determined to establish epithelial origin. Responsiveness to androgens and expression of androgen receptor and prostate specific antigen should be examined under stringent culture conditions to establish prostatic epithelial origin. Response to growth factors and expression of their receptors facilitates further characterization of cell behavior. Cell lines immortalized by human papillomaviruses (HPVs) are of special interest because HPVs are involved in a variety of anogenital cancers and may also play a role in prostate carcinogenesis. Malignant transformation of HPV-18 immortalized cells with the ras oncogene provides cell systems for investigating the multistep process of carcinogenesis. Each cell line has some unique characteristics, whether it arose directly from a carcinoma or resulted from immortalization with simian virus 40 (SV40) or HPV or was transformed in vitro by oncogenes. Comparisons of these characteristics should facilitate elucidation of the mechanisms involved in initiation, promotion, and progression of prostate cancer. These cell lines will further serve as useful models for investigating tumor progression, invasion, metastasis, new therapeutic strategies, drug resistance, and its reversal and chemoprevention. This review will be published in three parts and will summarize cell markers necessary for characterization, as well as the characteristics and some applications of the immortalized as well as malignant adult human prostatic epithelial cell lines. Part 1 deals with cell markers and the immortalized, nontumorigenic cell lines. © 1996 Wiley-Liss, Inc." @default.
• W2151493707 created "2016-06-24" @default.
• W2151493707 creator A5009525388 @default.
• W2151493707 creator A5044156119 @default.
• W2151493707 creator A5069412890 @default.
• W2151493707 date "1996-12-01" @default.
• W2151493707 modified "2023-09-26" @default.
• W2151493707 title "Immortalized and tumorigenic adult human prostatic epithelial cell lines: Characteristics and applications part I. Cell markers and immortalized nontumorigenic cell lines" @default.
• W2151493707 cites W11138111 @default.
• W2151493707 cites W1967684037 @default.
• W2151493707 cites W1970400570 @default.
• W2151493707 cites W1970679790 @default.
• W2151493707 cites W1970841622 @default.
• W2151493707 cites W1992985137 @default.
• W2151493707 cites W1997359043 @default.
• W2151493707 cites W1999001496 @default.
• W2151493707 cites W2002481689 @default.
• W2151493707 cites W2003990693 @default.
• W2151493707 cites W2004052832 @default.
• W2151493707 cites W2024881804 @default.
• W2151493707 cites W2027925208 @default.
• W2151493707 cites W2030819637 @default.
• W2151493707 cites W2033210006 @default.
• W2151493707 cites W2034696434 @default.
• W2151493707 cites W2041719533 @default.
• W2151493707 cites W2045219747 @default.
• W2151493707 cites W2061158088 @default.
• W2151493707 cites W2070742032 @default.
• W2151493707 cites W2070839157 @default.
• W2151493707 cites W2075453908 @default.
• W2151493707 cites W2089514388 @default.
• W2151493707 cites W2090041201 @default.
• W2151493707 cites W2094439724 @default.
• W2151493707 cites W2095348706 @default.
• W2151493707 cites W2104009810 @default.
• W2151493707 cites W2136888691 @default.
• W2151493707 cites W2166601147 @default.
• W2151493707 cites W2227583427 @default.
• W2151493707 cites W2322856508 @default.
• W2151493707 cites W2415266340 @default.
• W2151493707 cites W90643309 @default.
• W2151493707 doi "https://doi.org/10.1002/(sici)1097-0045(199612)29:6<386::aid-pros7>3.0.co;2-6" @default.
• W2151493707 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8977636" @default.
• W2151493707 hasPublicationYear "1996" @default.
• W2151493707 type Work @default.
• W2151493707 sameAs 2151493707 @default.
• W2151493707 citedByCount "74" @default.
• W2151493707 countsByYear W21514937072012 @default.
• W2151493707 countsByYear W21514937072013 @default.
• W2151493707 countsByYear W21514937072014 @default.
• W2151493707 countsByYear W21514937072015 @default.
• W2151493707 countsByYear W21514937072016 @default.
• W2151493707 countsByYear W21514937072017 @default.
• W2151493707 countsByYear W21514937072018 @default.
• W2151493707 countsByYear W21514937072019 @default.
• W2151493707 countsByYear W21514937072023 @default.
• W2151493707 crossrefType "journal-article" @default.
• W2151493707 hasAuthorship W2151493707A5009525388 @default.
• W2151493707 hasAuthorship W2151493707A5044156119 @default.
• W2151493707 hasAuthorship W2151493707A5069412890 @default.
• W2151493707 hasConcept C121608353 @default.
• W2151493707 hasConcept C1491633281 @default.
• W2151493707 hasConcept C203014093 @default.
• W2151493707 hasConcept C2776235491 @default.
• W2151493707 hasConcept C2779723316 @default.
• W2151493707 hasConcept C2780192828 @default.
• W2151493707 hasConcept C2781018059 @default.
• W2151493707 hasConcept C29537977 @default.
• W2151493707 hasConcept C502942594 @default.
• W2151493707 hasConcept C54355233 @default.
• W2151493707 hasConcept C555283112 @default.
• W2151493707 hasConcept C6045943 @default.
• W2151493707 hasConcept C81885089 @default.
• W2151493707 hasConcept C86803240 @default.
• W2151493707 hasConceptScore W2151493707C121608353 @default.
• W2151493707 hasConceptScore W2151493707C1491633281 @default.
• W2151493707 hasConceptScore W2151493707C203014093 @default.
• W2151493707 hasConceptScore W2151493707C2776235491 @default.
• W2151493707 hasConceptScore W2151493707C2779723316 @default.
• W2151493707 hasConceptScore W2151493707C2780192828 @default.
• W2151493707 hasConceptScore W2151493707C2781018059 @default.
• W2151493707 hasConceptScore W2151493707C29537977 @default.
• W2151493707 hasConceptScore W2151493707C502942594 @default.
• W2151493707 hasConceptScore W2151493707C54355233 @default.
• W2151493707 hasConceptScore W2151493707C555283112 @default.
• W2151493707 hasConceptScore W2151493707C6045943 @default.
• W2151493707 hasConceptScore W2151493707C81885089 @default.
• W2151493707 hasConceptScore W2151493707C86803240 @default.
• W2151493707 hasIssue "6" @default.
• W2151493707 hasLocation W21514937071 @default.
• W2151493707 hasLocation W21514937072 @default.
• W2151493707 hasOpenAccess W2151493707 @default.
• W2151493707 hasPrimaryLocation W21514937071 @default.
• W2151493707 hasRelatedWork W1897112873 @default.
• W2151493707 hasRelatedWork W2052103316 @default.
• W2151493707 hasRelatedWork W2062995999 @default.
• W2151493707 hasRelatedWork W2414304002 @default.
• W2151493707 hasRelatedWork W2467622083 @default.

• next